Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study

Rheumatology International

Volumn 34, Issue 12, 2014, Pages 1647-1655

  He, Yi ting ^a   Ou, Ai hua ^a   Yang, Xiao bo ^a   Chen, Wei ^a   Fu, Li yuan ^a   Lu, Ai ping ^b   Yan, Xiao ping ^c   Feng, Xing hua ^b   Su, Li ^d   Song, Yue jin ^e   Zeng, Sheng ping ^f   Liu, Wei ^g   Qian, Xian ^h   Zhu, Wan hua ⁱ   Lao, Ying rong ^a   Xu, Wei hua ^a   Wen, Ze huai ^a   He, Xiao hong ^a   Wang, Bao juan ^a   Chen, Geng xin ^a   Xue, Su qin ^a   more..

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e Institute of Traditional Chinese Medicine of Hubei Province   (China)

^f CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^g TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^h AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

ⁱ Nantong Hospital of Traditional Chinese Medicine   (China)

Author keywords

Randomized; Rheumatoid arthritis; Single blind; Therapy; Traditional Chinese Medicine; Western medicine

Indexed keywords

ANTIRHEUMATIC AGENT; HERBACEOUS AGENT; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTHRITIS, RHEUMATOID; CHINA; CHINESE MEDICINE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DRUG ADMINISTRATION; HUMAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SINGLE BLIND PROCEDURE; TIME; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHINA; DRUG ADMINISTRATION SCHEDULE; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; METHOTREXATE; REMISSION INDUCTION; SINGLE-BLIND METHOD; SULFASALAZINE; TIME FACTORS; TREATMENT OUTCOME; WESTERN WORLD;

EID: 84939893580     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3010-6     Document Type: Article

References (33)

1. Tang FL (1998) Strengthening experimental researches of rheumatoid arthritis in early diagnosis. Chin J Rheumatol 2(1):1
2. Boffeta P, Kaldor JM (1994) Secondary malignancies following cancer chemotherapy. Acta Oncol 33:591
3. Zhang YB (2005) Recent advances on pathogenesis and treatment of RA. J Cell Mol Immunol 21(1):88–90
4. State Administration of Traditional Chinese Medicine (1994) Standard of the People’s Republic of China specification: the criteria for diagnosis and syndromes in traditional Chinese medicine. Nanjing University Publishing House, Nanjing, pp 29–30 Chinese
5. Wang ZM, Bai RX (1989) Integrated medical dignosis and treatment criteria for four rheumatoid diseases. Zhong Xi Yi Jie He Za Zhi 9(1):52–53. Chinese
6. Li YL (2004) The advance on treating RA with traditional chinese medicine. J Guangxi Trad Chin Med Univ 7(3):81–83
7. Fu ZT, Huang WX, Yuan J (2005) Clinical research progress of RA treated by chinese medicine. Hunan J Trad Chin Med 21(4):93–95
8. Ye RG (2000) Internal medicine, 5th, People Public Health Publishing Company, p 900
9. Clinical Research Criteria on Treating Arthralgia Disease by Chinese Herbs (1993) Ministry of Health of PRC. Beijing, China
10. Zheng XY (2002) Clinical research criteria on treating RA by Chinese herbs. Med Sci Technol Press China 5:115–119
11. State Administration of Chinese Medicine (1994) Criteria of diagnosis and therapeutic effect of diseases and syndromes in traditional Chinese medicine. Nanjing University Press 7:29–30
12. Lu ZZ, Jiao SD (1996) Diagnostic criteria of national integrated traditional and western academic conference on Rheumatism (1988). People Public Health Publishing Company 456:16
13. Tsang IK (2007) Establishing the efficacy of traditional Chinese medicine. Nat Clin Pract Rheumatol 3(2):60–61
14. Li Z (1997) New practical medical statistics and skills. The medicine science and technology press of China, p 182
15. Felson DT, Anderson JJ et al (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727–735
16. Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178
17. American College of Rheumatology subcommittee on rheumatoid arthritis guidelines: guidelines for the management of rheumatoid arthritis 2002 update (2002) Arthritis Rheum 46:328–346
18. Islam MN, Alam MN et al (2000) Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis. Bangladesh Med Res Count Bull. 26(1):1–7
19. Aringer M, Graninger WB (2002) Treating rheumatoid arthritis with new disease modifying drugs. Acta Med Austriaca 29(1):33–35
20. Lu SJ, Shao J et al (2002) Clinical observation on treatment of rheumatoid arthritis by combined therapy with methotrexate, sulfasalazine and Chinese Herbal Medicine. Chin J Integr Trad West Med 22(8):571–573
21. Quinn MA, Conaghan PG et al (2001) Early rheumatoid arthritis (RA) 12 month results from a large secondary care multi-centre study using step-up combination therapy. Oxford University Press 3:37
22. Proudman SM, Conaghan PG et al (2000) Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 43(8):809–819
23. Dougados M, Combe B et al (1999) Combination therapy in early rheumatoid arthritis: a randomized, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 58(4):220–225
24. Liu J, Zheng ZJ (2000) Discussion of mechanism of rheumatoid arthritis in Traditional Chinese Medicine. China J Basic Med Trad Chin Med 7(9):13–14
25. Jiao SD (1998) Abstract of JIAO Shu-de Clinical Experience, 1st edition. The medicine science and technology press of China, Beijing, pp 84–109
26. Zhang JL (2005) Application of non-steroid anti-inflammatory drugs in the treatment of RA. Chin J Gen Pract 4(3):141–142
27. Ma L (2005) Application of DMARDs in the treatment of RA. Chin J Gen Pract 4(3):739–749
28. Huang MG (2002) Treatment of rheumatoid arthritis by Chinese medicine in 42 cases. Shanghai J Trad Chin Med 17(5):18–19
29. Shao XM, Fang JQ (2004) A new idea on the treatment of rheumatoid arthritis by TCM. J Zhejiang College TCM 28(4):15–16
30. Anderson JJ, Well G, Verhoeven AC, Felson DT (2000) Factors predicting responses to treatment in rheumatoid arthritis. Importance of disease duration. Arthritis Rheumat 43(1):22–29
31. Zhang NZ (1999) Clinical Rheumatology. Shanghai Science & Technology Press, Shanghai, p 132
32. Klinkhoff A (2004) Biological agents for rheumatoid arthritis: targeting both physical function and structural damage. Drugs 64:1267–1283
33. St. Clair EW, Wagner CL et al (2002) The relationship between infliximab concentration to clinic improvement in rheumatoid arthritis: results from ATTRACT, a mult-center randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:1451–1459